Zhejiang Ausun Pharmaceutical Co Ltd
SSE:603229
Wall Street
Price Targets
Price Targets Summary
Zhejiang Ausun Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Zhejiang Ausun Pharmaceutical Co Ltd is 20.8 CNY with a low forecast of 20.6 CNY and a high forecast of 21.41 CNY.
Revenue
Forecast
Revenue Estimate
Zhejiang Ausun Pharmaceutical Co Ltd
For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 27%.
Operating Income
Forecast
Operating Income Estimate
Zhejiang Ausun Pharmaceutical Co Ltd
For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's operating income is 18%. The projected CAGR for the next 3 years is 35%.
Net Income
Forecast
Net Income Estimate
Zhejiang Ausun Pharmaceutical Co Ltd
For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 31%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Zhejiang Ausun Pharmaceutical Co Ltd's stock price target?
Price Target
20.8
CNY
According to Wall Street analysts, the average 1-year price target for Zhejiang Ausun Pharmaceutical Co Ltd is 20.8 CNY with a low forecast of 20.6 CNY and a high forecast of 21.41 CNY.
What is Zhejiang Ausun Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
27%
For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 27%.
What is Zhejiang Ausun Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
35%
For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's operating income is 18%. The projected CAGR for the next 3 years is 35%.
What is Zhejiang Ausun Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
31%
For the last 7 years the compound annual growth rate for Zhejiang Ausun Pharmaceutical Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 31%.